Purple Biotech announces receipt of Nasdaq minimum bid price notification

* Purple Biotech Ltd (NASDAQ:PPBT [https://seekingalpha.com/symbol/PPBT]) said on Monday it received a notice from Nasdaq that its American Depositary Shares (ADSs) have been below the $1 minimum bid price required for continued listing for 30 consecutive trading days.
* The company has 180 days, until April 14, 2026, to regain compliance by maintaining a closing price of $1 or more for ten consecutive business days.
* If unsuccessful, Nasdaq may grant an additional 180-day cure period, subject to other listing requirements.
* Trading of PPBT ADSs will continue during the compliance period.
* PPBT closed -5.24% at $0.576.
* Source: Press Release [https://seekingalpha.com/pr/20272366-purple-biotech-announces-receipt-of-nasdaq-minimum-bid-price-notification]

MORE ON PURPLE BIOTECH

* Purple Biotech prices $6M public offering, $12M potential via warrants; shares down [https://seekingalpha.com/news/4492341-purple-biotech-prices-6m-public-offering-12m-potential-via-warrants-shares-down]
* Seeking Alpha’s Quant Rating on Purple Biotech [https://seekingalpha.com/symbol/PPBT/ratings/quant-ratings]
* Historical earnings data for Purple Biotech [https://seekingalpha.com/symbol/PPBT/earnings]
* Financial information for Purple Biotech [https://seekingalpha.com/symbol/PPBT/income-statement]